Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   myofibroma
  

Disease ID 652
Disease myofibroma
Definition

Uterine fibroids are the most common benign tumors in women of childbearing age. Fibroids are made of muscle cells and other tissues that grow in and around the wall of the uterus, or womb. The cause of fibroids is unknown. Risk factors include being African American or being overweight.

Many women with fibroids have no symptoms. If you do have symptoms, they may include

  • Heavy or painful periods or bleeding between periods
  • Feeling "full" in the lower abdomen
  • Urinating often
  • Pain during sex
  • Lower back pain
  • Reproductive problems, such as infertility, multiple miscarriages or early labor

Your health care provider may find fibroids during a gynecological exam or by using imaging tests. Treatment includes drugs that can slow or stop their growth, or surgery. If you have no symptoms, you may not even need treatment. Many women with fibroids can get pregnant naturally. For those who cannot, infertility treatments may help.

NIH: National Institute of Child Health and Human Development


Synonym
benign uterine leiomyomas
body of uterus fibroid
body of uterus leiomyoma
corpus uteri fibroid
corpus uteri leiomyoma
fibroid of body of uterus
fibroid of corpus uteri
fibroid of the body of uterus
fibroid of the corpus uteri
fibroid of the uterine body
fibroid of the uterine corpus
fibroid of uterine body
fibroid of uterine corpus
fibroid uterus
fibroid, uterine
fibroids, uterine
fibroleiomyoma
fibroma, uterine
fibromas, uterine
leiomyoma (disorder)
leiomyoma of body of uterus
leiomyoma of corpus uteri
leiomyoma of the body of uterus
leiomyoma of the corpus uteri
leiomyoma of the uterine body
leiomyoma of the uterine corpus
leiomyoma of uterine body
leiomyoma of uterine corpus
leiomyoma of uterus
leiomyoma of uterus, unspecified
leiomyoma, no icd-o subtype
leiomyoma, no icd-o subtype (morphologic abnormality)
leiomyoma, no international classification of diseases for oncology subtype
leiomyoma, no international classification of diseases for oncology subtype (morphologic abnormality)
leiomyoma, uterine
tumor of uterine muscle
uterine body fibroid
uterine body leiomyoma
uterine corpus fibroid
uterine corpus leiomyoma
uterine corpus leiomyomata
uterine fibroid
uterine fibroid (disorder)
uterine fibroids
uterine fibroma
uterine fibromas
uterine fibromyoma
uterine leiomyoma
uterine leiomyoma (disorder)
uterine leiomyoma - fibroids
uterine leiomyoma nos
uterine leiomyoma nos (disorder)
uterine leiomyoma, nos
uterine leiomyomas
uterine leiomyomas, benign
uterine leiomyomata
uterine myoma
uterus fibroid
uterus fibroids
uterus fibroma
uterus leiomyoma
uterus myoma
uterus, fibroid
uterus, fibroids
uterus, fibromyoma
uterus, leiomyoma
uterus, myoma
OMIM
DOID
ICD10
UMLS
C0042133
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:2)
C0010417  |  undescended testis  |  1
C0021843  |  intestinal obstruction  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:2)
TNRC6B  |  23112  |  GWASCAT
BET1L  |  51272  |  GWASCAT
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:9)
1586  |  CYP17A1  |  infer
1543  |  CYP1A1  |  infer
1553  |  CYP2A13  |  infer
1312  |  COMT  |  infer
2099  |  ESR1  |  infer
4312  |  MMP1  |  infer
4318  |  MMP9  |  infer
285  |  ANGPT2  |  infer
7157  |  TP53  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:272)
51015  |  ISOC1  |  DISEASES
9812  |  KIAA0141  |  DISEASES
3294  |  HSD17B2  |  DISEASES
7205  |  TRIP6  |  DISEASES
2099  |  ESR1  |  DISEASES
124  |  ADH1A  |  DISEASES
6300  |  MAPK12  |  DISEASES
10454  |  TAB1  |  DISEASES
9506  |  PAGE4  |  DISEASES
7076  |  TIMP1  |  DISEASES
4313  |  MMP2  |  DISEASES
7249  |  TSC2  |  DISEASES
3163  |  HMOX2  |  DISEASES
54108  |  CHRAC1  |  DISEASES
268  |  AMH  |  DISEASES
59284  |  CACNG7  |  DISEASES
3912  |  LAMB1  |  DISEASES
10282  |  BET1  |  DISEASES
5118  |  PCOLCE  |  DISEASES
5054  |  SERPINE1  |  DISEASES
4232  |  MEST  |  DISEASES
2662  |  GDF10  |  DISEASES
1277  |  COL1A1  |  DISEASES
595  |  CCND1  |  DISEASES
4617  |  MYF5  |  DISEASES
2735  |  GLI1  |  DISEASES
2026  |  ENO2  |  DISEASES
374291  |  NDUFS7  |  DISEASES
7043  |  TGFB3  |  DISEASES
1843  |  DUSP1  |  DISEASES
1958  |  EGR1  |  DISEASES
4656  |  MYOG  |  DISEASES
3624  |  INHBA  |  DISEASES
5184  |  PEPD  |  DISEASES
3976  |  LIF  |  DISEASES
4654  |  MYOD1  |  DISEASES
64428  |  NARFL  |  DISEASES
2521  |  FUS  |  DISEASES
4853  |  NOTCH2  |  DISEASES
6927  |  HNF1A  |  DISEASES
1019  |  CDK4  |  DISEASES
1019  |  CDK4  |  DISEASES
6498  |  SKIL  |  DISEASES
1588  |  CYP19A1  |  DISEASES
1545  |  CYP1B1  |  DISEASES
2660  |  MSTN  |  DISEASES
5159  |  PDGFRB  |  DISEASES
9252  |  RPS6KA5  |  DISEASES
4087  |  SMAD2  |  DISEASES
8503  |  PIK3R3  |  DISEASES
7077  |  TIMP2  |  DISEASES
7515  |  XRCC1  |  DISEASES
5605  |  MAP2K2  |  DISEASES
5338  |  PLD2  |  DISEASES
4854  |  NOTCH3  |  DISEASES
3977  |  LIFR  |  DISEASES
10190  |  TXNDC9  |  DISEASES
2891  |  GRIA2  |  DISEASES
2247  |  FGF2  |  DISEASES
1788  |  DNMT3A  |  DISEASES
8626  |  TP63  |  DISEASES
10016  |  PDCD6  |  DISEASES
1462  |  VCAN  |  DISEASES
1950  |  EGF  |  DISEASES
1017  |  CDK2  |  DISEASES
5925  |  RB1  |  DISEASES
3480  |  IGF1R  |  DISEASES
9611  |  NCOR1  |  DISEASES
7157  |  TP53  |  DISEASES
7157  |  TP53  |  DISEASES
207  |  AKT1  |  DISEASES
6282  |  S100A11  |  DISEASES
1513  |  CTSK  |  DISEASES
80731  |  THSD7B  |  DISEASES
23092  |  ARHGAP26  |  DISEASES
53336  |  CPXCR1  |  DISEASES
2796  |  GNRH1  |  DISEASES
4851  |  NOTCH1  |  DISEASES
133  |  ADM  |  DISEASES
60496  |  AASDHPPT  |  DISEASES
8404  |  SPARCL1  |  DISEASES
2697  |  GJA1  |  DISEASES
3206  |  HOXA10  |  DISEASES
7476  |  WNT7A  |  DISEASES
7476  |  WNT7A  |  DISEASES
201163  |  FLCN  |  DISEASES
9947  |  MAGEC1  |  DISEASES
7411  |  VBP1  |  DISEASES
5468  |  PPARG  |  DISEASES
3815  |  KIT  |  DISEASES
3815  |  KIT  |  DISEASES
9133  |  CCNB2  |  DISEASES
909  |  CD1A  |  DISEASES
30818  |  KCNIP3  |  DISEASES
1293  |  COL6A3  |  DISEASES
10466  |  COG5  |  DISEASES
5001  |  ORC5  |  DISEASES
1345  |  COX6C  |  DISEASES
122042  |  RXFP2  |  DISEASES
7248  |  TSC1  |  DISEASES
4314  |  MMP3  |  DISEASES
11318  |  GPR182  |  DISEASES
5617  |  PRL  |  DISEASES
3479  |  IGF1  |  DISEASES
59350  |  RXFP1  |  DISEASES
3688  |  ITGB1  |  DISEASES
613  |  BCR  |  DISEASES
118429  |  ANTXR2  |  DISEASES
2353  |  FOS  |  DISEASES
7532  |  YWHAG  |  DISEASES
8462  |  KLF11  |  DISEASES
150353  |  DNAJB7  |  DISEASES
4323  |  MMP14  |  DISEASES
3159  |  HMGA1  |  DISEASES
9940  |  DLEC1  |  DISEASES
91272  |  BOD1  |  DISEASES
947  |  CD34  |  DISEASES
947  |  CD34  |  DISEASES
56945  |  MRPS22  |  DISEASES
836  |  CASP3  |  DISEASES
7423  |  VEGFB  |  DISEASES
8837  |  CFLAR  |  DISEASES
4026  |  LPP  |  DISEASES
27319  |  BHLHE22  |  DISEASES
8490  |  RGS5  |  DISEASES
11145  |  PLA2G16  |  DISEASES
23428  |  SLC7A8  |  DISEASES
8648  |  NCOA1  |  DISEASES
1400  |  CRMP1  |  DISEASES
3039  |  HBA1  |  DISEASES
5426  |  POLE  |  DISEASES
4312  |  MMP1  |  DISEASES
7791  |  ZYX  |  DISEASES
5518  |  PPP2R1A  |  DISEASES
5241  |  PGR  |  DISEASES
5241  |  PGR  |  DISEASES
4670  |  HNRNPM  |  DISEASES
7025  |  NR2F1  |  DISEASES
633  |  BGN  |  DISEASES
8905  |  AP1S2  |  DISEASES
64764  |  CREB3L2  |  DISEASES
5121  |  PCP4  |  DISEASES
63827  |  BCAN  |  DISEASES
1553  |  CYP2A13  |  DISEASES
4088  |  SMAD3  |  DISEASES
93974  |  ATPIF1  |  DISEASES
57820  |  CCNB1IP1  |  DISEASES
9166  |  EBAG9  |  DISEASES
23583  |  SMUG1  |  DISEASES
2885  |  GRB2  |  DISEASES
93  |  ACVR2B  |  DISEASES
375341  |  C3orf62  |  DISEASES
8816  |  DCAF5  |  DISEASES
54345  |  SOX18  |  DISEASES
6318  |  SERPINB4  |  DISEASES
28986  |  MAGEH1  |  DISEASES
2100  |  ESR2  |  DISEASES
1499  |  CTNNB1  |  DISEASES
900  |  CCNG1  |  DISEASES
2331  |  FMOD  |  DISEASES
3914  |  LAMB3  |  DISEASES
440738  |  MAP1LC3C  |  DISEASES
60  |  ACTB  |  DISEASES
56980  |  PRDM10  |  DISEASES
7048  |  TGFBR2  |  DISEASES
4217  |  MAP3K5  |  DISEASES
26509  |  MYOF  |  DISEASES
4151  |  MB  |  DISEASES
2114  |  ETS2  |  DISEASES
1284  |  COL4A2  |  DISEASES
8682  |  PEA15  |  DISEASES
4311  |  MME  |  DISEASES
140803  |  TRPM6  |  DISEASES
9753  |  ZSCAN12  |  DISEASES
1312  |  COMT  |  DISEASES
2475  |  MTOR  |  DISEASES
800  |  CALD1  |  DISEASES
800  |  CALD1  |  DISEASES
4779  |  NFE2L1  |  DISEASES
57713  |  SFMBT2  |  DISEASES
3151  |  HMGN2  |  DISEASES
2271  |  FH  |  DISEASES
6000  |  RGS7  |  DISEASES
142  |  PARP1  |  DISEASES
5743  |  PTGS2  |  DISEASES
1805  |  DPT  |  DISEASES
11266  |  DUSP12  |  DISEASES
1382  |  CRABP2  |  DISEASES
6277  |  S100A6  |  DISEASES
3713  |  IVL  |  DISEASES
3713  |  IVL  |  DISEASES
23097  |  CDK19  |  DISEASES
1586  |  CYP17A1  |  DISEASES
2564  |  GABRE  |  DISEASES
60495  |  HPSE2  |  DISEASES
5223  |  PGAM1  |  DISEASES
1791  |  DNTT  |  DISEASES
7410  |  VAV2  |  DISEASES
7422  |  VEGFA  |  DISEASES
8643  |  PTCH2  |  DISEASES
284656  |  EPHA10  |  DISEASES
27328  |  PCDH11X  |  DISEASES
219738  |  C10orf35  |  DISEASES
8668  |  EIF3I  |  DISEASES
23633  |  KPNA6  |  DISEASES
26190  |  FBXW2  |  DISEASES
9968  |  MED12  |  DISEASES
57134  |  MAN1C1  |  DISEASES
367  |  AR  |  DISEASES
4855  |  NOTCH4  |  DISEASES
4686  |  NCBP1  |  DISEASES
1910  |  EDNRB  |  DISEASES
56998  |  CTNNBIP1  |  DISEASES
6497  |  SKI  |  DISEASES
7163  |  TPD52  |  DISEASES
1906  |  EDN1  |  DISEASES
10186  |  LHFP  |  DISEASES
7222  |  TRPC3  |  DISEASES
7223  |  TRPC4  |  DISEASES
1543  |  CYP1A1  |  DISEASES
7010  |  TEK  |  DISEASES
795  |  S100G  |  DISEASES
6462  |  SHBG  |  DISEASES
1280  |  COL2A1  |  DISEASES
4781  |  NFIB  |  DISEASES
171482  |  FAM9A  |  DISEASES
3486  |  IGFBP3  |  DISEASES
2315  |  MLANA  |  DISEASES
1024  |  CDK8  |  DISEASES
5888  |  RAD51  |  DISEASES
51272  |  BET1L  |  DISEASES
284001  |  CCDC57  |  DISEASES
6710  |  SPTB  |  DISEASES
12  |  SERPINA3  |  DISEASES
23023  |  TMCC1  |  DISEASES
7026  |  NR2F2  |  DISEASES
79868  |  ALG13  |  DISEASES
983  |  CDK1  |  DISEASES
5744  |  PTHLH  |  DISEASES
2120  |  ETV6  |  DISEASES
8091  |  HMGA2  |  DISEASES
8091  |  HMGA2  |  DISEASES
2199  |  FBLN2  |  DISEASES
5970  |  RELA  |  DISEASES
2531  |  KDSR  |  DISEASES
3238  |  HOXD12  |  DISEASES
29072  |  SETD2  |  DISEASES
200424  |  TET3  |  DISEASES
3481  |  IGF2  |  DISEASES
3800  |  KIF5C  |  DISEASES
23040  |  MYT1L  |  DISEASES
387836  |  CLEC2A  |  DISEASES
6464  |  SHC1  |  DISEASES
93649  |  MYOCD  |  DISEASES
23112  |  TNRC6B  |  DISEASES
2195  |  FAT1  |  DISEASES
2741  |  GLRA1  |  DISEASES
4193  |  MDM2  |  DISEASES
4193  |  MDM2  |  DISEASES
5890  |  RAD51B  |  DISEASES
57537  |  SORCS2  |  DISEASES
55998  |  NXF5  |  DISEASES
1750  |  DLX6  |  DISEASES
892  |  CCNC  |  DISEASES
4603  |  MYBL1  |  DISEASES
200150  |  PLD5  |  DISEASES
3250  |  HPR  |  DISEASES
91  |  ACVR1B  |  DISEASES
375612  |  LHFPL3  |  DISEASES
3292  |  HSD17B1  |  DISEASES
100506495  |  LIFR-AS1  |  DISEASES
4553  |  MT-TA  |  DISEASES
Locus(Waiting for update.)
Disease ID 652
Disease myofibroma
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:6)
HP:0100749  |  Thoracic pain  |  1
HP:0005234  |  Neonatal intestinal obstruction  |  1
HP:0000028  |  Cryptorchidism  |  1
HP:0400008  |  Menometrorrhagia  |  1
HP:0005214  |  Bowel obstruction  |  1
HP:0012531  |  Pain  |  1
Disease ID 652
Disease myofibroma
Manually Symptom(Waiting for update.)
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:53)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs1048943247770391545CYP1B1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0010857672014CYP1A11574720644TG,C,A
rs1048943247770391312COMTumls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0024429772014CYP1A11574720644TG,C,A
rs1048943243207361545CYP1B1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0010857672013CYP1A11574720644TG,C,A
rs1048943243207361312COMTumls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0024429772013CYP1A11574720644TG,C,A
rs1048943205596491543CYP1A1umls:C0042133BeFreeWe concluded that the carriage of CYP1A1 Ile462Val AG and CYP1B1 Leu 432Val CC genotypes predict the susceptibility to leiomyoma in Egyptian women and they are likely to contribute in the pathogenesis of leiomyoma.0.0037242412011CYP1A11574720644TG,C,A
rs1048943247770391543CYP1A1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0037242412014CYP1A11574720644TG,C,A
rs1048943243207361543CYP1A1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0037242412013CYP1A11574720644TG,C,A
rs1056827243207361312COMTumls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0024429772013CYP1B1;LOC105374860238075034CA
rs1056827247770391312COMTumls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0024429772014CYP1B1;LOC105374860238075034CA
rs1056827243207361543CYP1A1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0037242412013CYP1B1;LOC105374860238075034CA
rs1056827247770391545CYP1B1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0010857672014CYP1B1;LOC105374860238075034CA
rs1056827243207361545CYP1B1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0010857672013CYP1B1;LOC105374860238075034CA
rs1056827247770391543CYP1A1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0037242412014CYP1B1;LOC105374860238075034CA
rs1056836243207361312COMTumls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0024429772013CYP1B1238071060GC
rs1056836205596491543CYP1A1umls:C0042133BeFreeWe concluded that the carriage of CYP1A1 Ile462Val AG and CYP1B1 Leu 432Val CC genotypes predict the susceptibility to leiomyoma in Egyptian women and they are likely to contribute in the pathogenesis of leiomyoma.0.0037242412011CYP1B1238071060GC
rs1056836247770391312COMTumls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0024429772014CYP1B1238071060GC
rs1056836247770391543CYP1A1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0037242412014CYP1B1238071060GC
rs1056836243207361543CYP1A1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0037242412013CYP1B1238071060GC
rs1056836243207361545CYP1B1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0010857672013CYP1B1238071060GC
rs1056836247770391545CYP1B1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0010857672014CYP1B1238071060GC
rs1065827247770391543CYP1A1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0037242412014NANANANANA
rs1065827247770391545CYP1B1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0010857672014NANANANANA
rs1065827247770391312COMTumls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0024429772014NANANANANA
rs124847762146084223112TNRC6Bumls:C0042133GWASCATA genome-wide association study identifies three loci associated with susceptibility to uterine fibroids.0.1202714422011TNRC6B2240256869AG
rs128004382489027156288PARD3umls:C0042133BeFreeThree of 12 polymorphisms were associated with UL at the nominal significance level: rs4944957 and rs12800438 near DHCR7 and rs6058017 in ASIP.0.0002714422014NADSYN11171459957GA
rs12800438248902711717DHCR7umls:C0042133BeFreeThree of 12 polymorphisms were associated with UL at the nominal significance level: rs4944957 and rs12800438 near DHCR7 and rs6058017 in ASIP.0.0002714422014NADSYN11171459957GA
rs22805432389254010282BET1umls:C0042133BeFreeMeta-analysis showed a strong association at blocked early in transport 1 homolog (BET1L) rs2280543 for intramural UFs (meta-OR = 0.51, standard error (SE) = 0.14, Q = 0.590, I = 0, p = 2.48 × 10(-6)), which is stronger than the overall association with UF risk.0.0002714422013BET1L11203788CT
rs22805432146084251272BET1Lumls:C0042133GWASCATA genome-wide association study identifies three loci associated with susceptibility to uterine fibroids.0.1205428842011BET1L11203788CT
rs22805432389254051272BET1Lumls:C0042133BeFreeMeta-analysis showed a strong association at blocked early in transport 1 homolog (BET1L) rs2280543 for intramural UFs (meta-OR = 0.51, standard error (SE) = 0.14, Q = 0.590, I = 0, p = 2.48 × 10(-6)), which is stronger than the overall association with UF risk.0.1205428842013BET1L11203788CT
rs25487157609507515XRCC1umls:C0042133BeFreeDNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma.0.0008143262005XRCC11943551574TC
rs3087869247770391543CYP1A1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0037242412014COMT2219953984AG
rs3087869247770391312COMTumls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0024429772014COMT2219953984AG
rs3087869247770391545CYP1B1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0010857672014COMT2219953984AG
rs386493716157609507515XRCC1umls:C0042133BeFreeDNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma.0.0008143262005NANANANANA
rs4646422243207361312COMTumls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0024429772013CYP1A11574722964CT
rs4646422243207361545CYP1B1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0010857672013CYP1A11574722964CT
rs4646422247770391545CYP1B1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0010857672014CYP1A11574722964CT
rs4646422243207361543CYP1A1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0037242412013CYP1A11574722964CT
rs4646422247770391543CYP1A1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0037242412014CYP1A11574722964CT
rs4646422247770391312COMTumls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0024429772014CYP1A11574722964CT
rs4680239394691312COMTumls:C0042133BeFreeThe associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).0.0024429772013COMT;MIR47612219963748GA
rs4680243207361312COMTumls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0024429772013COMT;MIR47612219963748GA
rs4680247770391545CYP1B1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0010857672014COMT;MIR47612219963748GA
rs4680243207361543CYP1A1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0037242412013COMT;MIR47612219963748GA
rs4680247770391312COMTumls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0024429772014COMT;MIR47612219963748GA
rs4680247770391543CYP1A1umls:C0042133BeFreeThe genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (Val158Met) (OR 5.675, 95% CI 2.696-11.942) loci on COMT, rs1048943 (Ile462Val) (OR 4.629, 95% CI 2.216-9.672) and rs4646422 (Gly45Asp) (OR 3.240, 95% CI 1.624-6.461) loci on CYP1A1 and rs1065827 (Ala119Ser) (OR 5.635, 95% CI 2.990-10.619) locus on CYP1B1 were the risk factors to UL development and rs1056836 (Leu432Val) (OR 0.188, 95% CI 0.061-0.575) locus on CYB1B1 may be the protective factor to UL.0.0037242412014COMT;MIR47612219963748GA
rs4680243207361545CYP1B1umls:C0042133BeFreeThe genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in CYP1A1 and Ala119Ser loci in CYP1B1 were risk factors for uterine leiomyoma development, and Leu432Val locus in CYB1B1 may be a protective factor.0.0010857672013COMT;MIR47612219963748GA
rs49449572489027156288PARD3umls:C0042133BeFreeThree of 12 polymorphisms were associated with UL at the nominal significance level: rs4944957 and rs12800438 near DHCR7 and rs6058017 in ASIP.0.0002714422014NADSYN11171456989AG
rs4944957248902711717DHCR7umls:C0042133BeFreeThree of 12 polymorphisms were associated with UL at the nominal significance level: rs4944957 and rs12800438 near DHCR7 and rs6058017 in ASIP.0.0002714422014NADSYN11171456989AG
rs60580172489027156288PARD3umls:C0042133BeFreeThree of 12 polymorphisms were associated with UL at the nominal significance level: rs4944957 and rs12800438 near DHCR7 and rs6058017 in ASIP.0.0002714422014AHCY;ASIP2034269192AG
rs6058017248902711717DHCR7umls:C0042133BeFreeThree of 12 polymorphisms were associated with UL at the nominal significance level: rs4944957 and rs12800438 near DHCR7 and rs6058017 in ASIP.0.0002714422014AHCY;ASIP2034269192AG
rs662257926525444PON1umls:C0042133BeFreeThe effects of PON1 gene Q192R variant on the development of uterine leiomyoma in Turkish patients.0.0002714422015PON1795308134TC
rs791306921460842102724351LOC102724351umls:C0042133GWASCATA genome-wide association study identifies three loci associated with susceptibility to uterine fibroids.0.122011LOC10272435110103954641CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:74)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
15545452rs9729637GTrs9729637230404930.0000295NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
15548512rs9786944GArs9786944230404930.0000824NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
119987294rs6693503AGrs6693503230404930.0000161NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
122414785rs2268179GTrs2268179230404930.00000134NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
126666502rs12563321CTrs12563321230404930.0000287NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
126676257rs10902742GTrs10902742230404930.0000591NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
127497582rs12117956AGrs12117956230404930.0000397NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
127537101rs6687674GArs6687674230404930.0000467NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
168912755rs2012235TCrs2012235230404930.0000209NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1191133789rs1454356CArs1454356230404930.0000642NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1221377435rs4846689ACrs4846689230404930.0000436NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
27606695rs12692335CTrs12692335230404930.000069NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
259282591rs991964TCrs991964214608429.00E-06NA1.15[1.03-1.28] 1,607 Japanese ancestry cases; 1,428 Japanese ancestry controlsJapanese(3035)ALL(3035)ASN(3035)ALL(3035)Uterine fibroidsHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidD007889LeiomyomaEFOID:0000731uterine fibroidUterine fibroidsrs991964-AResearch Support, Non-U.S. Gov'tGFLJ30838
4176582766rs2333255CArs2333255230404930.000028NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
5132111043rs30523GArs30523230404930.0000152NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
680985885rs627240CArs627240230404930.0000904NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
6112861788rs6926282GArs6926282230404930.0000855NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
6138525847rs6903101TCrs6903101230404930.0000439NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
8118946541rs10955841GArs10955841230404930.0000752NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
985261201rs11139665TGrs11139665230404930.00000784NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
9113043999rs1556047GArs1556047230404930.0000683NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
9138314255rs7855598AGrs7855598230404930.0000406NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1026352952rs11593128CArs11593128230404930.0000604NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1026353592rs1521032GArs1521032230404930.0000541NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1026355906rs3824700GArs3824700230404930.0000492NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1026382351rs1521033TCrs1521033230404930.0000889NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1028579969rs3936497AGrs3936497230404930.0000634NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
10105714399rs7913069CTrs7913069214608429.00E-14NA1.47[1.23-1.75]1,607 Japanese ancestry cases; 1,428 Japanese ancestry controlsJapanese(3035)ALL(3035)ASN(3035)ALL(3035)Uterine fibroidsHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidD007889LeiomyomaEFOID:0000731uterine fibroidUterine fibroidsrs7913069-AResearch Support, Non-U.S. Gov'tTNA
11203788rs2280543CTrs2280543214608424.00E-12NA1.39[1.17-1.64]1,607 Japanese ancestry cases; 1,428 Japanese ancestry controlsJapanese(3035)ALL(3035)ASN(3035)ALL(3035)Uterine fibroidsHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidD007889LeiomyomaEFOID:0000731uterine fibroidUterine fibroidsrs2280543-GResearch Support, Non-U.S. Gov'tCBET1L
11131657770rs7945105GArs7945105230404930.0000493NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1294665793rs12579612AGrs12579612230404930.0000875NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
12103125690rs2172873GArs2172873214608422.00E-06NA1.18[1.04-1.34] 1,607 Japanese ancestry cases; 1,428 Japanese ancestry controlsJapanese(3035)ALL(3035)ASN(3035)ALL(3035)Uterine fibroidsHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidD007889LeiomyomaEFOID:0000731uterine fibroidUterine fibroidsrs2172873-AResearch Support, Non-U.S. Gov'tTNA
1426077408rs1951054TCrs1951054230404930.0000186NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1478015897rs2284230CTrs2284230230404930.0000488NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1499492973rs1257670GArs1257670230404930.0000363NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1580553207rs2903332CTrs2903332230404930.0000031NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1599120152rs11636483GArs11636483230404930.0000944NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1680396925rs16953111GArs16953111230404930.0000983NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1715034841rs917538CArs917538230404930.0000461NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780082060rs6502057AGrs6502057230404930.00000306NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780085633rs11077969AGrs11077969230404930.00000391NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780085703rs7213172GC,Trs7213172230404930.00000423NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780086389rs7406163CTrs7406163230404930.00000446NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780087337rs7221544CTrs7221544230404930.00000626NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780102279rs8080423AGrs8080423230404930.00000436NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780131879rs7502078CArs7502078230404930.00000404NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.000000745NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.000000842NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.00000186NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.00000219NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.00000649NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.00000688NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.00000725NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.00000796NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.00000849NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000116NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000117NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000146NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000147NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000155NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000171NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000182NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000183NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000207NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000215NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000236NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000238NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000245NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000265NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404930.0000278NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1780166989rs4247357GTrs4247357230404933.05E-08NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2122896615rs13049184TCrs13049184230404930.000087NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2228015322rs732110ACrs732110230404930.0000089NANANAUp to 1230 European ancestry cases; 5097 European ancestry controlsEuropean(6327)ALL(6327)EUR(6327)ALL(6327)Uterine leiomyomataHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidNANANANAUterine fibroidsNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2240652873rs12484776AGrs12484776214608423.00E-12NA1.23[1.11-1.37]1,607 Japanese ancestry cases; 1,428 Japanese ancestry controlsJapanese(3035)ALL(3035)ASN(3035)ALL(3035)Uterine fibroidsHPOID:0000131Uterine leiomyomaDOID:13223uterine fibroidD007889LeiomyomaEFOID:0000731uterine fibroidUterine fibroidsrs12484776-GResearch Support, Non-U.S. Gov'tATNRC6B
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)